Tralokinumab: Exploring the Potential of LP 0162 and CAT-354 Tralokinumab, previously known as LP 0162 and CAT-354, represents a novel approach for atopic dermatitis. This specific antibody targets IL-13, a https://amaanegxs654431.activoblog.com/profile